Insulin therapy, vital for diabetes management, is often misunderstood. It's not a sign of failure or addiction, nor does it ...

Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in Canada.

CHICAGO — Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in ...

CHICAGO, December 10, 2024--(BUSINESS WIRE)--Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin ...

Cipla secures CDSCO approval for Afrezza, a rapid-acting insulin delivered through an inhaler, offering a convenient solution ...

Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in Canada.

Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...

CHICAGO, December 10, 2024--(BUSINESS WIRE)--Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin ...